How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

When Not to Use Muscle Relaxants, How Frequent is Loneliness in RA/P…

RheumNow

J. Cush

Management of Raynaud’s Phenomenon

John D. Pauling

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Vasculitis Treatment Update

Keck School of Medicine of USC

K. Ruddy

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Daniel Arkfeld

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Top Shoulder Problems You See in the Office

UCSF School of Medicine

B. Feeley

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Cleveland Clinic Rheumatology

A. Villa-Forte

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

Methotrexate and the Gut Microbiome

RheumNow

R. Blank

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush

Rheumatoid Arthritis: Update on Treatment Strategies

University of Colorado Department of Medicine

L. W. Moreland

USSONAR Rheumatology Ultrasound Case Series: Rheumatoid Arthritis an…

USSONAR

J. Yinh

Interstitial Lung Disease: Multidisciplinary Discussion

UCLA Health

S. Sam Weigt, E. R. Volkmann, F. Abtin, M. Fishbein

ACR Convergence 2023 Highlights: Embedding Treat to Target Principle…

Highlights from ACR Convergence 2023

S. Dowell

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat